At recruitment and at study entry, women were asked to complete a questionnaire.
In every evening diary entry, participants were asked to rate the subjective usefulness of the feedback using predefined answers.
Among these four A, B, C, and D alternative items in each entry, they were asked to choose the one that they thought to be correct.
At the end of the inpatient period (3 – 4 weeks after entry), participants were asked to fill in the third questionnaire set (ME3).
In every evening diary entry, participants were asked about the subjective usefulness of the feedback by two questions with predefined answers to choose from.
The reason is: While at study entry patients were asked about therapies and health services during the preceding 12 months, these items were thereafter asked every six months (medicine use also after three months).
Both at recruitment and at current study entry, women were asked specifically whether they had ever been diagnosed with breast cancer and if so, details of diagnosis date and details of treating physician.
Patients were assessed for disease activity and those who met entry criteria were asked to discontinue their current NSAID use and return for evaluation when symptoms worsened (disease flare).
At trial entry, participants were asked about their awareness of OC risk factors and views about putative benefits of screening, to identify possible misunderstandings or gaps in knowledge that might influence willingness to adhere to screening.
At each Street Entry Event participants were asked to press one of three buttons to make the judgement.
